Valuation: Ainos, Inc.

Market Cap 1.05Cr 90.52L 84.92L 77.35L 1.45Cr 100.25Cr 1.47Cr 9.96Cr 3.9Cr 50Cr 3.94Cr 3.85Cr 167.08Cr P/E 2024
-0.29x
P/E 2025 -0.47x
Enterprise Value 2.11Cr 1.82Cr 1.71Cr 1.55Cr 2.92Cr 201.44Cr 2.96Cr 20Cr 7.84Cr 100.92Cr 7.91Cr 7.74Cr 335.71Cr EV / Sales 2024
701x
EV / Sales 2025 162x
Free-Float
24.76%
Yield 2024 *
-
Yield 2025 -
1 week-0.70%
Current month+6.77%
1 month-13.94%
3 months-14.45%
6 months+6.77%
Current year-13.41%
1 week 1.38
Extreme 1.38
1.56
1 month 1.3
Extreme 1.3
1.7
Current year 1.26
Extreme 1.26
3.88
1 year 1.26
Extreme 1.26
4.44
3 years 1.26
Extreme 1.26
21.6
5 years 1.26
Extreme 1.26
450
10 years 1.26
Extreme 1.26
1,781.25
Manager TitleAgeSince
Chief Executive Officer 56 15/04/2021
Director of Finance/CFO 54 15/03/2024
Director TitleAgeSince
Director/Board Member 49 15/04/2021
Director/Board Member 54 15/04/2021
Director/Board Member 42 15/04/2021
Date Insider Type Main position Quantity % Market Cap.
19/05/26 Buy

Director

2,200 0.0315%
29/04/26 Buy

Director

300 0.0041%
28/01/26
Taiwan Carbon Nano Technology Corp.
SellCompany 46,000 0.6588%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-0.70%-57.61%-91.08% 1.05Cr
-0.47%-2.36%+20.09%+9.25% 22TCr
+0.09%-3.22%-3.05%-19.85% 14TCr
-1.06%-0.78%-18.90%+34.56% 14TCr
-0.77%+1.92%-50.09%+0.96% 7.51TCr
-0.86%-1.33%+15.98%+18.20% 5.28TCr
-0.79%-1.29%-17.14%-16.13% 5.07TCr
-0.05%-0.18%+25.65%+22.84% 4.19TCr
-1.07%-0.98%+40.89%+49.27% 4.05TCr
-1.79%-0.78%-1.09%+5.82% 3.33TCr
Average -0.51%+0.98%-4.53%+1.38% 7.94TCr
Weighted average by Cap. -0.34%+1.12%+0.26%+9.28%

Financials

2024 2025
Net sales 20.73T 17.9T 16.79T 15.29T 28.75T 19.82L 29.15T 2L 77.12T 10L 77.82T 76.14T 33.03L 1L 1L 1L 91.59T 2L 1.19Cr 2L 11.79L 5L 59.47L 5L 5L 1.98Cr
Net income -1.49Cr -1.28Cr -1.2Cr -1.1Cr -2.06Cr -142.11Cr -2.09Cr -14Cr -5.53Cr -71Cr -5.58Cr -5.46Cr -236.84Cr -1.48Cr -1.28Cr -1.2Cr -1.09Cr -2.05Cr -141.23Cr -2.08Cr -14Cr -5.5Cr -71Cr -5.55Cr -5.43Cr -235.37Cr
Net Debt 81.07L 69.99L 65.66L 59.8L 1.12Cr 78Cr 1.14Cr 7.7Cr 3.02Cr 39Cr 3.04Cr 2.98Cr 129.18Cr 1.06Cr 91.36L 85.71L 78.07L 1.47Cr 101.18Cr 1.49Cr 10Cr 3.94Cr 51Cr 3.97Cr 3.89Cr 168.63Cr
Logo Ainos, Inc.
Ainos, Inc. is a dual-platform AI and biotech company advancing SmellTech and immune therapeutics. Its AI Nose platform and smell language model (SML) digitize scent into Smell ID, a machine-readable data, powering applications across robotics, smart factories, and healthcare. It is also developing VELDONA, an oral low-dose interferon therapy targeting rare diseases, autoimmune diseases, infectious diseases, and animal health. Its pipeline includes drug candidates for treating oral warts for human immunodeficiency virus seropositive patients, Sjogren’s syndrome, and feline chronic gingivostomatitis, a cat oral infection. Its product pipeline includes VELDONA Pet, VELDONA human drugs, AI Nose - NISD co-development, AI Nose industrial and robotics application, VOC POCT, VOC POCT Ainos Pen, VOC POCT CHS430, and Synthetic RNA (SRNA). VOC POCT-Ainos Pen is a device intended to be a cloud-connected, multipurpose, portable breath analyzer that is intended to monitor health conditions.
Employees
41
Date Price Change Volume
18/26/18 $1.420 0.00% 1,88,039
14/26/14 $1.420 -1.39% 21,186
13/26/13 $1.440 -3.36% 14,393
12/26/12 $1.490 +0.68% 42,625
11/26/11 $1.480 +3.50% 12,037
  1. Stock Market
  2. Stocks
  3. AIMD Stock